F. Bensch

No picture available
E-mail:
f.bensch umcg.nl

Research

  1. 2021
  2. 2019
  3. Jauw, Y. W. S., Bensch, F., Brouwers, A. H., Hoekstra, O. S., Zijlstra, J. M., Pieplenbosch, S., Schröder, C. P., Zweegman, S., van Dongen, G. A. M. S., van Oordt, C. W. M. D. H., de Vries, E. G. E., de Vet, H. C. W., Boellaard, R., & Huisman, M. C. (2019). Interobserver reproducibility of tumor uptake quantification with Zr-89-immuno-PET: a multicenter analysis. European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1840-1849. https://doi.org/10.1007/s00259-019-04377-6
  4. 2018
  5. 2017
  6. 2015
  7. Lamberts, T. E., Menke-van der Houven van Oordt, C. W., Ter Weele, E. J., Bensch, F., Smeenk, M. M., Voortman, J., Hoekstra, O. S., Williams, S. P., Fine, B. M., Maslyar, D., de Jong, J. R., Gietema, J. A., Schröder, C. P., Bongaerts, A. H. H., Lub-de Hooge, M. N., Verheul, H. M. W., Sanabria Bohorquez, S., Glaudemans, A. W. J. M., & de Vries, E. G. (2015). ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment. Clinical Cancer Research, 22(7), 1642-1652. https://doi.org/10.1158/1078-0432.CCR-15-1272
  8. 2014
  9. Lamberts, L. E., Menke-van der Houven van Oordt, C. W., Bensch, F., Voortman, J., Hoekstra, O. S., Maslyar, D., Williams, S. P., Fine, B. M., Bongaerts, A. H., Gietema, J. A., Schroder, C. P., Weele, E. J. T., Hooge, M. N. L-D., Verheul, H. M., Sanabria, S., Glaudemans, A. W. J. M., & Vries, de, E. G. E. (2014). 1627PPET-IMAGING WITH 89ZR-LABELED ANTI-MESOTHELIN (MSLN) ANTIBODY IN PATIENTS WITH PANCREATIC CANCER (PC) OR OVARIAN CANCER (OC). Annals of Oncology, 25(Supplement 4), iv562. https://doi.org/10.1093/annonc/mdu358.58
  10. 2013

ID: 380859